GCM
Glenview Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265M | Buy |
15,824,223
+1,045,582
| +7% | +$17.5M | 7.43% | 4 |
|
|
2025
Q1 | $227M | Buy |
14,778,641
+6,322,317
| +75% | +$97.2M | 5.58% | 4 |
|
|
2024
Q4 | $186M | Hold |
8,456,324
| – | – | 4.71% | 5 |
|
|
2024
Q3 | $152M | Sell |
8,456,324
-701,317
| -8% | -$12.6M | 2.95% | 10 |
|
|
2024
Q2 | $149M | Buy |
9,157,641
+1,656,357
| +22% | +$26.9M | 2.93% | 11 |
|
|
2024
Q1 | $106M | Buy |
7,501,284
+5,896,651
| +367% | +$83.2M | 1.85% | 14 |
|
|
2023
Q4 | $16.8M | Buy |
+1,604,633
| New | +$16.8M | 0.36% | 32 |
|
|
2016
Q4 | – | Sell |
-2,176,144
| Closed | -$100M | – | 51 |
|
|
2016
Q3 | $100M | Sell |
2,176,144
-906,703
| -29% | -$41.7M | 0.72% | 32 |
|
|
2016
Q2 | $155M | Sell |
3,082,847
-2,496,465
| -45% | -$125M | 1.09% | 25 |
|
|
2016
Q1 | $299M | Sell |
5,579,312
-376,484
| -6% | -$20.1M | 2.18% | 16 |
|
|
2015
Q4 | $391M | Buy |
5,955,796
+1,767,017
| +42% | +$116M | 2.2% | 17 |
|
|
2015
Q3 | $236M | Buy |
4,188,779
+1,344,379
| +47% | +$75.9M | 1.17% | 31 |
|
|
2015
Q2 | $168M | Buy |
+2,844,400
| New | +$168M | 0.67% | 48 |
|